31 December 2019 - Deborah Wilkes
Premium
Australia's Advisory Committee on Medicines Scheduling (ACMS) will consider applications to switch several medicines – adapalene, ondansetron, rizatriptan and melatonin – from pre-scription to non-prescription status at its next meeting in March 2020.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.